Erdheim-Chester disease: A challenging diagnosis for an effective therapy: Clinical Neurology and Neurosurgery

A. Todisco, C. Cavaliere, A. Vaglio, M. Marano, A. Bonometti, E. Passoni, E. Berti, M. Cirillo, G. Cirillo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number105841
JournalClin. Neurol. Neurosurg.
Volume194
DOIs
Publication statusPublished - 2020

Keywords

  • BRAF
  • Erdheim-Chester disease
  • non-Langerhans cell histiocytosis
  • Ponto-cerebellar syndrome
  • Vemurafenib
  • CD163 antigen
  • chlordane
  • fascin
  • fluorodeoxyglucose f 18
  • meprednisone
  • protein S 100
  • t6 antigen
  • vemurafenib
  • adult
  • Article
  • ataxia
  • ataxic gait
  • case report
  • cerebellar ataxic gait
  • clinical article
  • dysarthria
  • dysphagia
  • Erdheim Chester disease
  • false negative result
  • histiocytosis
  • human
  • human tissue
  • hypopituitarism
  • immunohistochemistry
  • Langerhans cell
  • male
  • mesencephalon
  • middle aged
  • motor dysfunction assessment
  • neuroimaging
  • nuclear magnetic resonance imaging
  • nystagmus
  • pyrosequencing
  • scale for the assessment and rating of ataxia
  • skin biopsy
  • slurred speech
  • superior cerebellar peduncle
  • whole body MRI

Cite this